secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zura Bio Ltd (ZURA)
CIK:        0001855644
Form:       8-K
Filed at:   2026-01-26T23:59:59+00:00
Accession:  0001104659-26-006326
Event type: leadership
Sentiment:  neutral
Materiality: 0.90
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Zura Bio announces CEO resignation and appointment of Sandeep Kulkarni as new CEO
--------------------------------------------------------------------------------

- Robert Lisicki resigned as CEO and director effective January 21, 2026, after medical leave since October 2025.
- Dr. Sandeep Kulkarni appointed CEO and continues as director; will receive $655,000 base salary and equity awards.
- Separation agreement with Lisicki includes $72,000 annualized transition compensation through March 31, 2026.
- Parvinder Thiara appointed to board effective January 23, 2026; previously served from 2022 to 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855644/000110465926006326/0001104659-26-006326-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855644/000110465926006326/tm263758d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-006326

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer